References
- Braillon A, Naudet F. Baclofen and the “first do not harm” motto: a new French paradox? Clin Toxicol. 2017. [Epub ahead of print]. doi: 10.1080/15563650.2017.1366501
- Rolland B, Paille F, Fleury B, et al. Off-label baclofen prescribing practices among French alcohol specialists: results of a national online survey. PLoS One. 2014;9:e98062.
- Baldwin DS, Tiwari N, Gordon R. Sense and sensibility when prescribing ‘off-label’ to psychiatric patients. Curr Pharm Des. 2015;21:3276–3279.
- Rolland B, Paille F, Gillet C, et al. Pharmacotherapy for alcohol dependence: the 2015 recommendations of the French Alcohol Society, issued in partnership with the European Federation of Addiction Societies. CNS Neurosci Ther. 2016;22:25–37.
- Reynaud M, Aubin HJ, Trinquet F, et al. A randomized, placebo-controlled study of high-dose baclofen in alcohol-dependent patients – the ALPADIR study. Alcohol Alcohol. 2017;52:439–446.